All Cosmos Bio-Tech (ACB-KY) March 2026 Revenue NT$214 million (YoY -18.6%)
All Cosmos Bio-Tech's monthly revenue for March 2026 was NT$214 million, a decrease of 18.6% year-over-year. The company is classified in the biotechnology and medical care industry.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 12, 2026 at 21:27 (4h 57m after Collected)
All Cosmos Bio-Tech (ACB-KY) (Stock Code: 4148), a company in the Biotechnology and Medical Care industry, announced its revenue for March 2026. The monthly revenue reached 213,712 thousand NTD (approximately NT$214 million), which marks an 18.6% decrease compared to the same month last year.